Zometa Plus Quadramet, Metastron For Bone Tumors Subject Of NCI-Funded Study
This article was originally published in The Pink Sheet Daily
Executive Summary
Study will evaluate whether a radionucleotide plus a bisphosphonate can treat metastases caused by lung, breast, prostate cancer.